Rosai-Dorfman disease masquerading as chronic ankle arthritis: A case report and review of the literature [6]

Rheumatology

Volumn 43, Issue 6, 2004, Pages 811-812

  Gupta, Sandeep ^a   Finzel, K C ^b   Grubber, B L ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; INFLIXIMAB; INTERFERON; MERCAPTOPURINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THALIDOMIDE;

ADULT; ANKLE PAIN; ANKLE RADIOGRAPHY; ARTHRITIS; CASE REPORT; DISEASE COURSE; DRUG ERUPTION; EXAMINATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; ROSAI DORFMAN DISEASE; SEROLOGY; WEIGHT BEARING;

EID: 3042551128     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh179     Document Type: Letter

References (10)

1. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): Review of the entity. Semin Diagn Pathol 1990;7:19-73.
2. Walker PD, Rosai J, Dorfman R. The osseous manifestations of sinus histiocytosis with massive lymphadenopathy. Am J Clin Pathol 1981;75:131-9.
3. Pulsoni A, Anghel G, Falcucci P et al. Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): Report of a case with literature review. Am J Hematol 2002;69:67-71.
4. Komp DM. The treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Semin Diagn Pathol 1990;7:83-6.
5. Lohr HF, Godderz W, Wolfe T et al. Long term survival in a patient with Rosai-Dorfman disease treated with Interferon alpha. Eur J Cancer 1995;31A:2427-8.
6. McAlister WH, Herman T, Dehner LP. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). 1990;20:425-32.
7. Nawroz IM, Wilson-Storey D. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Histopathology 1989; 14:91-9.
8. Tjiu J-W, Hsiao C-H, Tsai T-F. Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment. Br J Dermatol 2003;148: 1058-9.
9. Maarten Egeler R, Favara BE, Meurs MV, Lamann JD, Claassen E. Differential in situ cytokine profile of langerhans-like cells and T cells in langerhans cell histiocytosis: Abundant expression of cytokines relevant to disease and treatment. Blood 1999;94:4195-201.
10. Henter J-I, Karlen J, Calming U, Bernstrand C, Andersson U, Fadeel B. Successful treatment of Langerhans' cell histiocytosis with etanercept. N Engl J Med 2001;345:1577-78.